FINWIRES · TerminalLIVE
FINWIRES

SHE:300676

2 stories mentioning SHE:300676Updated 38d ago

Every FINWIRES story that references SHE:300676, newest first.

Asia

BGI Genomics Upgrades NIFTY Test Kit with New Model

BGI Genomics (SHE:300676) secured the approval of China's drug regulator for changes to its NIFTY prenatal testing kit.The changes add the NIFTY-B model and expand instrument compatibility to include the DNBSEQ-G99 sequencer, according to a Thursday filing with the Shenzhen bourse. The kit is used to screen for fetal chromosomal abnormalities.Shares of the genomics services provider closed 5% lower Friday.

SHE:300676
Asia

BGI Genomics Gets Proposal from Controlling Shareholder to Repurchase Up to 500 Million Yuan Shares

BGI Genomics (SHE:300676) received a proposal from controlling shareholder Shenzhen BGI Genomics Technology to repurchase between 250 million yuan and 500 million yuan of shares, according to a Tuesday after-market filing.

SHE:300676

Track with the FINWIRES app suite

FolioX
FolioX
Track SHE:300676 in your portfolio
WheelAI
WheelAI
Analyze SHE:300676 options with the wheel strategy
StockInsider
StockInsider
See market sentiment on SHE:300676